9 results
8-K
EX-99.1
SDGR
Schrödinger, Inc.
1 May 24
Schrödinger Reports First Quarter 2024 Financial Results
4:01pm
the First Time Disclosure Session at the American Chemical Society Spring 2024 Meeting. The presentation provided an overview of how Schrödinger
8-K
EX-99.1
SDGR
Schrödinger, Inc.
28 Feb 24
Schrödinger Reports Strong Fourth Quarter and Full-Year 2023 Financial Results
4:06pm
, a pharmacodynamic goal of the study.
Schrödinger presented preclinical data for SGR-1505 at the American Society of Hematology (ASH) Annual Meeting
8-K
EX-99.1
SDGR
Schrödinger, Inc.
3 Nov 22
Schrödinger Reports Third Quarter 2022 Financial Results
4:01pm
Society of Hematology 2022 Annual Meeting
New York, November 3, 2022 – Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform … Society of Hematology (ASH) 64th Annual Meeting in December 2022. The data demonstrate the strong anti-tumor activity of SGR-2921 in preclinical
8-K
EX-99.1
gx7l 1ag1h
24 Feb 22
Schrödinger Reports Financial Results for the Fourth Quarter and Full Year 2021
4:06pm
8-K
EX-99.1
z4r3sed5hoaw9a ji84s
10 Nov 21
Schrödinger Reports Third Quarter 2021 Financial Results and Provides Company Update
4:05pm
8-K
EX-99.1
7lv2cm w28fy
4 Mar 21
Schrödinger Reports Financial Results for the Fourth Quarter and Full Year 2020 and Provides Outlook for 2021
7:15am
8-K
EX-99.1
terfdk labf3
12 Nov 20
Schrödinger, Inc. Reports Third Quarter 2020 Financial Results and Business Update
7:15am
- Prev
- 1
- Next